![Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY](https://www.touchimmunology.com/wp-content/uploads/sites/18/2023/02/TMM-IMMUNO-Jean-Frederic-Colombel-thumbnail.jpg)
Jean-Frederic Colombel, ECCO 2023: A sub-analysis investigating upadacitinib for rapid symptom relief in Crohn's disease - touchIMMUNOLOGY
![Sherman Prize on Twitter: "Dr Jean-Frederic Colombel of @IcahnMountSinai @MountSinaiNYC receives $100K Sherman Prize for groundbreaking research in IBD genetics, risk factors & treatment. https://t.co/hgrBKYjAwb https://t.co/1FoJJN6C8z" / Twitter Sherman Prize on Twitter: "Dr Jean-Frederic Colombel of @IcahnMountSinai @MountSinaiNYC receives $100K Sherman Prize for groundbreaking research in IBD genetics, risk factors & treatment. https://t.co/hgrBKYjAwb https://t.co/1FoJJN6C8z" / Twitter](https://pbs.twimg.com/media/DnEg_UkWwAELj8u.jpg)
Sherman Prize on Twitter: "Dr Jean-Frederic Colombel of @IcahnMountSinai @MountSinaiNYC receives $100K Sherman Prize for groundbreaking research in IBD genetics, risk factors & treatment. https://t.co/hgrBKYjAwb https://t.co/1FoJJN6C8z" / Twitter
![ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well ECCO 2016: Professor Jean-Frederic Colombel (New York, USA) and Dr James Lindsay (Barts and the London NHS Trust, UK) discuss new data from the GEMINI programme showing patient populations that do well](https://medicalupdateonline.com/wp-content/uploads/2016/05/ECCO-2016-Part-1-Update-from-GEMINI-Study.jpg)